Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
03/1998
03/12/1998WO1998009644A2 Method for lowering cholesterol levels
03/12/1998WO1998009630A1 Compounds and methods
03/12/1998WO1998009626A1 Methods for in vivo reduction of iron levels and compositions useful therefor
03/12/1998WO1998009625A1 SELECTIVE β3 ADRENERGIC AGONISTS
03/12/1998WO1998009533A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses
03/12/1998WO1998009526A1 Antioxidant derived from lentil and its preparation and uses
03/12/1998WO1998005792A3 A novel human leptin receptor gene-related protein
03/12/1998WO1997049827A3 Adenoviral mediated gene transfer in adipocytes and related implants
03/12/1998CA2795629A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses
03/12/1998CA2264965A1 Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
03/12/1998CA2264942A1 Compounds and methods
03/12/1998CA2264918A1 Method for lowering cholesterol levels
03/12/1998CA2264798A1 Indazole derivatives and their use as inhibitors of phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
03/12/1998CA2263686A1 Methods for in vivo reduction of iron levels and compositions useful therefor
03/11/1998EP0827959A2 Benzo[B]thiophene compounds, intermediates, processes, compositions, and methods
03/11/1998EP0827746A1 Carbazole analogues as selective B3 adrenergic agonists
03/11/1998EP0827509A1 Modulation of cholesteryl ester transfer protein (cetp) activity
03/11/1998EP0827408A1 Method of administration of igf-i
03/11/1998EP0827403A1 Use of calcium intracellular store inactivators and formulations thereof as cell growth inhibitors
03/11/1998EP0827401A2 Methods and compositions for inhibiting alpha-reductase activity
03/11/1998EP0785933B1 Indole derivatives as 5ht1-like agonists
03/11/1998EP0663902B1 25-carboxylic acid derivatives in the vitamin d series, pharmaceutical preparations containing these derivatives and their use in the manufacture of medicines
03/11/1998CN1175976A Arachidonic acid and method for production and use thereof
03/11/1998CN1175574A Cycloalkano-pyridines
03/11/1998CN1175573A Vitamin D3 analogs
03/11/1998CN1175572A Ortho-substd. benzoyl guanidine, its preparing method, use thereof and medicine contg. same
03/11/1998CN1175463A Anti-senility hypolipemic Chinese medicine liquor
03/11/1998CN1175424A Herb medicine for treating diabetes mellitus
03/11/1998CN1175407A Clear hydroalcoholic multivitamin solution containing physiologically effective amounts of beta-carotene
03/10/1998US5726307 Benzo-fused lactams promote release of growth hormone
03/10/1998US5726291 Amylase inhibitors
03/10/1998US5726284 Crosslinked polymric ammonium salts
03/10/1998US5726205 O-acyl-4-phenyl-cyclohexanols, their salts, medicaments containing such compounds and their use, as well as a method of preparing them
03/10/1998US5726201 Bis-(2-ethylhexyl)-sodium-sulfosuccinate surfactant; storage stability; uniform dissolution
03/10/1998US5726200 Treatment of obesity, gastrointestinal disorders, tumors, drug withdrawal; useful as antipsychotic, antianxiety, antiulcer agents;
03/10/1998US5726186 For treating post-menopausal syndrome, uterine fibroid disease, endometriosis and aortal smooth muscle cell proliferation
03/10/1998US5726168 Lipophilic benzothiophenes
03/10/1998US5726156 Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
03/10/1998US5726055 Process for the preparation of pharmaceutically active thiazolidine compounds by a yeast reductase
03/10/1998US5725873 Method of improving the growth or the efficiency of feed conversion of an animal and compositions for use therein
03/10/1998US5725854 Administering cells and immunology
03/05/1998WO1998008872A1 Glp-2 derivatives
03/05/1998WO1998008871A1 Glp-1 derivatives
03/05/1998WO1998008850A1 Spirocyclic metalloprotease inhibitors
03/05/1998WO1998008847A1 Substituted 6,5-hetero-bicyclic derivatives
03/05/1998WO1998008846A1 Substituted 6,6-hetero-bicyclic derivatives
03/05/1998WO1998008840A1 Integrin antagonists
03/05/1998WO1998008838A1 Substituted amine derivatives
03/05/1998WO1998008815A1 Substituted cyclic amine metalloprotease inhibitors
03/05/1998WO1998008797A1 Naphthyl compounds, intermediates, compositions, and methods of use
03/05/1998WO1998008545A1 Methods for treating disorders by using interleukin-9 and its antagonists
03/05/1998WO1998008531A1 Use of glp-1 or analogs in treatment of myocardial infarction
03/05/1998WO1998008529A1 Method of inhibiting fibrosis with a somatostatin agonist
03/05/1998WO1998008528A1 Method of inhibiting fibrosis with a somatostatin agonist
03/05/1998WO1998008518A1 Compositions and methods for administering integrin receptor antagonists
03/05/1998WO1998008513A1 Amorphous benzothiophenes, methods of preparation, and methods of use
03/05/1998WO1998008512A1 Methods of increasing sensitivity of an individual to ob protein by upregulating ob protein receptor
03/05/1998WO1997046226A3 USE OF INHIBITORS OF THE CELLULAR Na+/H+ EXCHANGER (NHE) FOR PREPARING A MEDICAMENT FOR NORMALIZING SERUM LIPIDS
03/05/1998WO1997037688A3 Pharmaceutical combination containing a compound having angiotensin ii and antagonistic activity
03/05/1998CA2264309A1 Method of inhibiting fibrosis with a somatostatin agonist
03/05/1998CA2264044A1 Spirocyclic metalloprotease inhibitors
03/05/1998CA2263999A1 Integrin antagonists
03/05/1998CA2263998A1 Compositions and methods for administering integrin receptor antagonists
03/05/1998CA2263935A1 Methods for treating disorders by using interleukin-9 and its antagonists
03/05/1998CA2263928A1 Substituted cyclic amine metalloprotease inhibitors
03/05/1998CA2263826A1 Methods of increasing sensitivity of an individual to ob protein by upregulating ob protein receptor
03/05/1998CA2263685A1 Use of glp-1 or analogs in treatment of myocardial infarction
03/05/1998CA2263175A1 Amorphous benzothiophenes, methods of preparation, and methods of use
03/04/1998EP0826682A1 Amorphous benzothiophenes, methods of preparation, and methods of use
03/04/1998EP0826679A2 Naphthyl compounds, intermediates, compositions, and method of use
03/04/1998EP0826657A1 Compounds for modulation of hormone receptors, compositions containing them and their use in therapy
03/04/1998EP0826375A2 Use of complex lipids as stabilizing additives for pharmaceutical preparations of digestive enzymes
03/04/1998EP0826369A1 Therapeutic use of dioxabicyclo (3.3.0)octane compounds
03/04/1998EP0826368A1 Use of retinoids for the preparation of a medicament for treating disorders related to VEGF overexpression
03/04/1998EP0826045A1 Nucleic acids for treating obesity
03/04/1998EP0826002A2 Biologically active peptide fragments of ob protein
03/04/1998EP0825993A1 Xanthines and their therapeutic use
03/04/1998EP0825986A1 Quinolyl-ethynyl derivatives having retinoid-like activity
03/04/1998EP0825984A1 Novel method
03/04/1998EP0825981A1 Novel heterocyclic compounds
03/04/1998EP0825872A1 Pharmaceutical administration form of parathyroid hormone having an active ingredient release period of from two to six hours
03/04/1998EP0825871A1 Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids
03/04/1998EP0825861A1 High-dose chromic tripicolinate for the treatment of type ii diabetes
03/04/1998EP0825855A1 Agents for reducing weight
03/04/1998EP0617614B1 Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
03/04/1998CN1175246A Substituted azetidin-2-ones for treatment of atherosclerosis
03/04/1998CN1175214A Petide P227 analogs, and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes
03/04/1998CN1174836A Novel imino derivatives as inhibitors of bone resorption and vitronectin receptor antagonists
03/04/1998CN1174833A Phenyl substituted alkenocarboxylic guanidine, preparation method, application as medicine or diagnostic agent adn medicine containing it
03/04/1998CN1174743A Application of composite fat used as stabilizing additive in medicine of digestive enzyme mixture
03/03/1998US5723606 Condensed benzazepine derivative and pharmaceutical composition thereof
03/03/1998US5723577 Analogs of parathyroid hormone
03/03/1998US5723489 Aryloxypropanolamine beta 3 adrenergic agonists
03/03/1998US5723476 4-hydroxycoumarin-3-carboxamides for the treatment of diabetes mellitus
03/03/1998US5723458 1,4-benzothiazepines
03/03/1998US5723456 Therapeutic treatment for cardiovascular diseases
03/03/1998US5723449 Antisecretory agents and anticarcinogenic agents
03/03/1998US5723441 Method of treating renal disease by administering IGF-I and IGFBP-3
03/03/1998US5723333 Vectors of oncogenes, promoters, transcription
03/03/1998US5723327 Hydrolyzes oligo- and polysaccharides with trehalose end unit; culturing sulfobus; foods, cosmetics, drugs
1 ... 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 ... 1298